Welcome to the Mass General Brigham Center for COVID Innovation
We are launching the second phase of MGBCCI: Diagnostics. Click below to fill out our questionnaire and join a working group or view a recording of our Diagnostics town hall.
Mass General Brigham Center for COVID Innovation
To our MGB Research Community:
It has been amazing to see the research community step up to address the COVID19 pandemic. Our investigators have initiated pre-clinical studies on coronavirus receptors, launched new clinical trials of promising antiviral agents, strategized about testing novel vaccines, and brainstormed novel ways to manufacture Personal Protective Equipment. All of these efforts reinforce what we already knew: MGB is great in a crisis.
In an effort to coordinate and facilitate the development of new innovations that flatten the COVID19 curve and protect and empower our front line clinical staff, we are launching an MGB Center for COVID Innovation. The Center will serve to: 1) identify and empower experts from inside and outside MGB that can move meritorious ideas towards practice, and 2) help identify internal and external resources necessary to operationalize these ideas. We encourage all MGB personnel to submit ideas for projects addressing the diagnosis, therapy, or clinical care of patients with coronavirus infection. Please email ideas to: firstname.lastname@example.org
Paul Anderson, M.D., Ph.D., Chief Academic Officer, BWH
Harry Orf, Ph.D., SVP of Research, MGH
Gary Tearney, M.D., Professor of Pathology, MGH
David Walt, Ph.D., Professor of Pathology, BWH